Gonadotropin-releasing hormone (GnRH) peptide analogs — the synthetic decapeptide agonists and antagonists controlling pituitary gonadotropin secretion representing the pharmacological cornerstone of ovarian stimulation in in-vitro fertilization — create the most commercially dynamic market segment, with the Human GnRH Peptide Market reflecting ART applications as the fertility...